Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

This publication has 25 references indexed in Scilit:

• Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial
  Circulation, 2002
• Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project
  European Heart Journal, 2002
• Long-term risk stratification for survivors of acute coronary syndromes
  Journal of the American College of Cardiology, 2001
• Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering
  The American Journal of Cardiology, 2000
• Pravastatin Therapy and the Risk of Stroke
  New England Journal of Medicine, 2000
• Hypercholesterolaemia as a risk factor for coronary heart disease in the Asia-Pacific region: The ASPAC study
  Atherosclerosis, 2000
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris
  The American Journal of Cardiology, 1995
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986